Identification of Vyvanse:
No description |
Search images on Google Product Monograph
Active Ingredients:
- lisdexamfetamine dimesylate, 50 MG
DIN: 02490269
Dosage Form(s): TABLET (CHEWABLE)
Route(s) of Administration: ORAL
Schedule: Schedule G (CDSA I)
Company: TAKEDA CANADA INC – official site
ATC:
- N06 - PSYCHOANALEPTICS (ATC, WHO, Wiki)
- N06B - PSYCHOSTIMULANTS, AGENTS USED FOR ADHD AND NOOTROPICS (ATC, WHO)
- N06BA - Centrally acting sympathomimetics (ATC, WHO)
- N06BA12 - LISDEXAMFETAMINE (WHO)
Reference brand drug: Vyvanse
External Links for Vyvanse:
Search on Google
- Vyvanse side effects
- Vyvanse dosage
- lisdexamfetamine dimesylate side effects
- lisdexamfetamine dimesylate dosage
Takeda Canada Inc
Go to Takeda website to see drug product details. Sometimes you can find vyvanse photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.